Subscribe To
MNOV / MediciNova Posts Promising Data From COVID-19 Treatment Candidate
MNOV News
By Proactive Investors
August 16, 2023
Medicinova stock up on European patent award
Medicinova Inc (NASDAQ:MNOV) stock started Wednesday on the front foot boosted by a patent award in Europe. The European Patent Office has given prote more_horizontal
By Benzinga
June 8, 2022
MediciNova Posts Promising Data From COVID-19 Treatment Candidate
MediciNova Inc (NASDAQ: MNOV) says the Phase 2 trial of MN-166 (ibudilast) in hospitalized COVID-19 patients demonstrated significant improvements more_horizontal